Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC
Claire M. Pfeffer(Purdue University West Lafayette), Brittany L. Allen-Petersen(Purdue University West Lafayette)
Cited by 0
Related Papers
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
|BioDrugs|2019|151
Loss of protein kinase C delta alters mammary gland development and apoptosis
|Cell Death and Disease|2010|25
PP2A activation drives aberrant macropinocytosis and cell death in pancreatic ductal adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0